Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Venous Thrombosis IV: Nursing Management
Pulmonary Embolism III: Nursing Management
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 15, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
1Surgical Intensive Care Units, Tufts-New England Medical Center and Surgery, Medicine & Anesthesia, Boston, USA.
Antithrombotic therapy, while crucial, carries litigation risks due to potential adverse events. This article shows how evidence-based guidelines, documentation, and communication can minimize errors in antithrombotic treatment.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: